Nateglinide
Nateglinide (pronunciation: /nəˈtɛɡlɪnaɪd/) is an oral medication used for the treatment of Type 2 diabetes. It belongs to the class of drugs known as meglitinides, which work by stimulating the release of insulin from the pancreas.
Etymology
The term "Nateglinide" is derived from its chemical name, which is 1-[[[2-[(3-phenyl-1,2,4-thiadiazol-5-yl)methyl]phenyl]amino]]acetyl]-D-glucitol. The "-glucitol" suffix indicates that the compound is a sugar alcohol, while the "nate" prefix is derived from the Latin "natus", meaning "born". The "gli" in the middle of the name is a common element in the names of drugs used to treat diabetes, indicating that the drug is a glucose-lowering agent.
Usage
Nateglinide is used in conjunction with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is usually taken three times a day, before each main meal. Nateglinide works by stimulating the body to produce more insulin, a natural substance that allows the body to properly use sugar from the diet.
Side Effects
Common side effects of Nateglinide include hypoglycemia (low blood sugar), dizziness, weight gain, joint pain, and flu-like symptoms. If these side effects persist or worsen, patients are advised to contact their healthcare provider immediately.
Related Terms
See Also
External links
- Medical encyclopedia article on Nateglinide
- Wikipedia's article - Nateglinide
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski